Key Highlights

● Aemetis reported second-quarter 2026 results on August 6, 2026, showing improved margins and a narrower net loss.

● The company produces California ethanol, dairy-based renewable natural gas, and India biodiesel across its diversified renewable fuels operations.

● A $116.7 million Debt deadline looms over the stock, a significant near-term financial pressure point.

● Investors are weighing the operational improvement against the company's ability to address the looming debt obligation.

Aemetis, Inc. (Nasdaq: AMTX), a Cupertino, California-based renewable fuels company producing California ethanol, dairy-based renewable Natural Gas (RNG), and India biodiesel, has drawn fresh investor attention after reporting improved second-quarter 2026 results on August 6. Revenue rose 20% year-over-year to $62.7 million, Gross Profit swung to a $13.5 million profit from a $3.4 million loss a year earlier, and net loss narrowed to $9.4 million from $23.4 million. The improvement was driven largely by higher ethanol pricing, a 38% jump in dairy RNG volumes, and $8.6 million in Section 45Z clean-fuel production tax credits. But the progress sits alongside a stockholders' Deficit of $322.1 million, total debt of $415.9 million, and management's own disclosure of "substantial doubt" about its ability to continue as a going concern.

Latest Development

Aemetis reported second-quarter 2026 results on August 6, 2026. Total revenue reached $62.7 million, up from $52.2 million a year earlier, though it fell short of the roughly $68.6 million analyst consensus cited by Stonegate Capital Partners, which updated its coverage on August 10 and called the quarter an "operating inflection" despite the top-line miss, noting normalized EPS of negative $0.11 versus a consensus estimate of negative $0.24.

Separately, on August 4, Aemetis' India subsidiary, Universal Biofuels, said it began delivering biodiesel under a new allocation from India's state-owned Oil Marketing Companies (OMCs) worth an expected $17 million over three months, covering more than 18 million liters. Executives framed the deliveries as evidence of a strengthening India biodiesel market, with the government targeting 5% biodiesel blending by 2030, up from roughly 1% today. Aemetis has also said it is preparing a possible minority-stake IPO of the India Subsidiary on an Indian exchange, subject to market conditions.

No single company-specific announcement could be independently verified as explaining any particular day's share-price move; the stock's 52-week range of $1.30 to $3.80 reflects a volatile, thinly capitalized name where sentiment swings with each Earnings or financing update.

What the Numbers Show

By segment, California ethanol remained the largest revenue contributor, with 15.5 million gallons sold at an average price of $2.19 per gallon, up 9% from $2.01; the Keyes plant ran at 113% of nameplate capacity. Dairy RNG volumes rose 38% to 146,900 MMBtu, with segment gross profit reportedly rising to $4.0 million from $0.9 million, per Stonegate. India biodiesel revenue was just $2.5 million, sharply lower than a year earlier, reflecting a near-total pause in OMC purchases before the August allocation; the plant ran at only about 3.6% of capacity.

Tax credits were a meaningful swing factor: Aemetis recognized $8.6 million in Section 45Z credits ($6.5 million ethanol, $2.1 million RNG), plus California LCFS Credit sales of 27,500 credits at an average $66, up from 14,000 at $55 a year earlier. First-half 2026 revenue totaled $117.3 million versus $95.1 million, including $12.6 million of Section 45Z credits, with adjusted EBITDA of $8.4 million versus negative $16.4 million in the same 2025 period.

The Balance Sheet is the more urgent story. As of June 30, 2026, Aemetis held just $973,000 in unrestricted cash (down from $4.9 million at year-end 2025), against total debt of $415.9 million, including $354.2 million classified as current. Interest expense alone was $15.2 million for the quarter. The 10-Q discloses that Aemetis Biogas's Series A preferred units, carrying a $116.7 million Redemption obligation, faced an August 31, 2026 deadline, already extended multiple times in prior amendments, with refinancing arrangements maturing September 1, 2027 not yet finalized as of the filing.

Why Investors Are Paying Attention

Aemetis sits at the intersection of several federal and state clean-fuel policy tailwinds: Section 45Z production tax credits, Section 45Q carbon-capture credits tied to its carbon-intensity reduction projects, and California's LCFS program, all now showing up meaningfully in revenue. The company's $40 million mechanical vapor recompression (MVR) project at its Keyes plant, designed to cut natural gas use roughly 80% using on-site solar and grid power, is expected to become operational later in 2026 and, per the company, could add roughly $32 million in annual operating cash flow. Dairy RNG, still the smallest segment by revenue, is growing fastest and carries the highest margins.

Bull Case

Bulls point to genuine operating improvement: gross margins turned positive, adjusted EBITDA moved from deeply negative to positive across two consecutive quarters, and dairy RNG, the highest-margin segment, is scaling quickly as new digesters come online. Section 45Z and LCFS credit monetization is a real and growing cash source rather than a one-time item. If the MVR project delivers its projected cash-flow benefit and India OMC purchasing continues, Margin trends could keep improving. The company is also pursuing multiple financing tracks, tax-exempt bond financing (California's CPCFA approved an initial resolution supporting up to $1.1 billion for Aemetis projects) and a potential India IPO, either of which could materially improve Liquidity if completed.

Bear Case

The bear case centers on solvency, not operations. Aemetis carries a stockholders' deficit of $322.1 million and total debt nearly 1.5 times total assets. Management's own 10-Q states there is substantial doubt about its ability to continue as a going concern, citing reliance on a senior secured lender, multiple past covenant waivers, and dependence on monetizing tax credits to fund operations. The $116.7 million Series A preferred redemption deadline of August 31, 2026 is imminent, and while similar deadlines have been extended repeatedly in the past, there is no guarantee of another extension or of completing the credit arrangements maturing in September 2027. India biodiesel revenue remains dependent on unpredictable government OMC allocations, and any disruption to Section 45Z, 45Q, or LCFS credit programs would remove a substantial, currently growing revenue source.

What Could Move the Stock Next?

Near-term catalysts include the outcome of the August 31, 2026 preferred-unit redemption deadline (extension, refinancing, or default), progress on CPCFA tax-exempt bond financing, commissioning of the Keyes MVR system, continued India OMC allocations, and any update on the potential Universal Biofuels IPO. Third-quarter results, expected in November, will show whether first-half operating gains are sustainable and whether cash burn has stabilized.

A Debt Clock Overshadowing Operational Gains

Aemetis presents a split picture: improving unit Economics in ethanol and dairy RNG, growing tax-credit revenue, and a re-engaged India biodiesel business, set against a balance sheet under acute strain and explicit going-concern language from management. The resolution of the August 31 preferred-unit redemption deadline is likely to matter more for the stock in the coming weeks than any single operating metric. Investors weighing the story should treat the operational improvements and the liquidity crisis as two separate, equally important threads, since either could dominate the next material move in the shares.